4️⃣Cabbot ring
➡️composition: remanent of mitosis spindle
🔬associations: MDS, megaloblastic anemia, AML
5️⃣Heinz body
➡️composition: unstable haemoglobin
🔬associations: unstable hemoglobin, G6PD deficiency and other erythrocytes enzyme deficiency, some hemoglobinopathies, alpha thalassemia
6️⃣Hemoglobin H
➡️composition: beta chain tetramers
🔬associations: a type of alpha thalassemia
End🧵
• • •
Missing some Tweet in this thread? You can try to
force a refresh
#mmsm Hematologica published 3 articles for sub-group analysis for Isatuximab recently:
1-IKEMA pts with renal failure-Full article 2- ICARIA-MM elderly pt-letter to editor
3-IKEMA+ICARIA-MM: 1q-letter to editor
🛑All used 1-2 medical writers
Was this all the story ? 🧵
Same medical writers helped in a review of key subgroup analysis of ICARIA-MM 👇
Also in doing another subgroup analysis in high risk cytogenetics
You think we are done: NO
ICARIA-MM subgroup analysis 👇
Expert review article with the help of medical writer 👇
#ASH21 Oral abstract:Ciltacabtagene Autoleucel for Triple-Class Exposed MM:Adjusted Comparisons of CARTITUDE-1 Patient Outcomes Versus Therapies from Real-World Clinical Practice from the LocoMMotion Prospective Study #mmsm 🧵
➡️ash.confex.com/ash/2021/webpr…
🛑some important issues👇
#ASH21#mmsm
➡️Cilta Cel is effective in difficult to ttt pts, this is not the aim of the discussion
➡️In this abstract,authors compared a prospectively matched triple class ref MM pts who received diff ttt vs Cilta cel
➡️ what did they find? 👇 (Cilta Cel better) but wait🛑
➡️Read results 👇
1️⃣countries:only 9% RWCP in US vs. 100% of pts who got Cilta Cel in CARTITUDE-1 were in US (16 Center) ➡️study compared pts across the ocean with diff access to ttt🙈
2️⃣>90 ttt options😅
3️⃣2 of the most frequently used regimens were doublet 🙈Kd (~14%),Pd (11%)
➡️ VOD (~15% ,all types): a bad complication with high mortality (severe type, historically >80%)
➡️ Diagnosis &grading(see tables👇) (nature.com/articles/bmt20…)
➡️Authors question: is defibrotide cost-effective using price input from Spain (note this is likely different from US)
➡️ Simplified definitions:
1⃣ Cost-effectiveness analysis(CEA) is usually measured by incremental cost-effectiveness ratio (ICER) and it establishes how much extra has to be paid for extra benefit.
Summary of cytoplasm/nucleus changes in leukocytes:
1️⃣ Hyposegmentation of neutrophils(peanut shaped, bilobed,or non-segmented nucleus with coarse chromatin)
🔬associations: Pelger–Huët anomaly(inherited) or pseudo-Pelger–Huët anomaly(acquired)
➡️Pelger–Huët anomaly(inherited):affect majority of granulocytes: autosomal dominant- mutations in the lamin B receptor gene
➡️Pseudo-Pelger–Huët anomaly(acquired): <50% of granulocytes: usually occurs with other morphological changes of malignancy: can see in MPNs or MDS #Heme
2️⃣Hypersegmentation of neutrophils
➡️≥ 6 lobes in granulocyte nucleus
🔬associations: megaloblastic anemia, chronic infections, MDS, familial(rare) #Heme